GL1X · GenesisL1 explorer

UniProt P63165

Small ubiquitin-related modifier 1 (P63165)

Small ubiquitin-related modifier 1 (UniProt P63165), EC 2.3.2.26: 103 experimental structures and 1 predicted model on GenesisL1, 4 ligands bound, 23 pockets. Binding sites, druggability and experiment against prediction…

UniProt
P63165
Protein
Small ubiquitin-related modifier 1
EC
2.3.2.26
Experimental structures
103
Predicted models
1
Ligands
4
Pockets
23 · 4 records with a druggable one

Structures

104 records of P63165 in the MolNFT archive: 103 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1A5RStructure determination of the small ubiquitin-related modifier sumo-1, NMR, 10 structuressolution nmrA——
1A5RStructure determination of the small ubiquitin-related modifier sumo- 1, NMR, 10 structuressolution nmrA——
1TGZStructure of human Senp2 in complex with SUMO-1x-ray diffractionB——
1TGZStructure of human SENP2 in complex with sumo-1x-ray diffractionB——
1WYWCrystal Structure of SUMO1-conjugated thymine DNA glycosylasex-ray diffractionB——
1WYWCrystal structure of SUMO1-conjugated thymine DNA glycosylasex-ray diffractionB——
1Y8RSumo E1 activating enzyme SAE1-SAE2-SUMO1-mg-ATP complexx-ray diffractionC, F——
1Y8RSumo E1 activating enzyme SAE1-SAE2-SUMO1-mg-ATP complexx-ray diffractionC, F——
1Z5SCrystal structure of a complex between UBC9, SUMO-1, RANGAP1 and NUP358/RANBP2x-ray diffractionB——
1Z5SCrystal structure of a complex between UBC9, sumo-1, RANGAP1 and NUP358/RANBP2x-ray diffractionB——
2ASQSolution Structure of SUMO-1 in Complex with a SUMO-binding Motif (SBM)solution nmrA——
2ASQSolution structure of sumo-1 in complex with a sumo-binding motif (sbm)solution nmrA——
2BF8Crystal structure of SUMO modified ubiquitin conjugating enzyme E2- 25Kx-ray diffractionB——
2BF8Crystal structure of sumo modified ubiquitin conjugating enzyme E2-25Kx-ray diffractionB——
2G4DCrystal structure of human SENP1 mutant (C603S) in complex with SUMO-1x-ray diffractionB, D——
2G4DCrystal structure of human SENP1 mutant (C603S) in complex with sumo-1x-ray diffractionB, D——
2IO2Crystal structure of human Senp2 in complex with RanGAP1-SUMO-1x-ray diffractionB——
2IO2Crystal structure of human SENP2 in complex with RANGAP1-sumo-1x-ray diffractionB——
2IY0SENP1 (mutant) SUMO1 RanGAPx-ray diffractionB——
2IY0SENP1 (mutant) SUMO1 rangapx-ray diffractionB——
2IY1SENP1 (mutant) full length SUMO1x-ray diffractionB, D——
2IY1SENP1 (mutant) full length SUMO1x-ray diffractionB, D——
2KQSPhosphorylation of SUMO-interacting motif by CK2 enhances Daxx SUMO binding activitysolution nmrA——
2KQSPhosphorylation of sumo-interacting motif by CK2 enhances daxx sumo binding activitysolution nmrA——
2LASMolecular Determinants of Paralogue-Specific SUMO-SIM Recognitionsolution nmrA——
2LASMolecular determinants of paralogue-specific sumo-sim recognitionsolution nmrA——
2MW5Backbone fold of Human Small Ubiquitin like Modifier protein-1 (SUMO-1) based on Prot3D-NMR…solution nmrA——
2MW5Backbone fold of human small ubiquitin like modifier protein-1 (sumo- 1) based on PROT3D-NMR…solution nmrA——
2N1ADocked structure between SUMO1 and ZZ-domain from CBPsolution nmrA——
2N1ADocked structure between SUMO1 and zz-domain from cbpsolution nmrA——
2N1VSolution structure of human SUMO1solution nmrA——
2N1VSolution structure of human SUMO1solution nmrA——
2PE6Non-covalent complex between human SUMO-1 and human Ubc9x-ray diffractionB——
2PE6Non-covalent complex between human sumo-1 and human UBC9x-ray diffractionB——
2UYZNon-covalent complex between Ubc9 and SUMO1x-ray diffractionB——
2UYZNon-covalent complex between UBC9 and SUMO1x-ray diffractionB——
2VRRStructure of SUMO modified Ubc9x-ray diffractionB——
2VRRStructure of sumo modified UBC9x-ray diffractionB——
3KYCHuman SUMO E1 complex with a SUMO1-AMP mimicx-ray diffractionD——
3KYCHuman sumo E1 complex with a SUMO1-AMP mimicx-ray diffractionD——
3KYDHuman SUMO E1~SUMO1-AMP tetrahedral intermediate mimicx-ray diffractionD——
3KYDHuman sumo E1~SUMO1-AMP tetrahedral intermediate mimicx-ray diffractionD——
3RZWCrystal Structure of the Monobody ySMB-9 bound to human SUMO1x-ray diffractionC, D——
3RZWCrystal structure of the monobody ysmb-9 bound to human SUMO1x-ray diffractionC, D——
3UIPComplex between human RanGAP1-SUMO1, UBC9 and the IR1 domain from RanBP2 containing IR2 Motif IIx-ray diffractionB——
3UIPComplex between human RANGAP1-SUMO1, UBC9 and the IR1 domain from RANBP2 containing IR2 motif IIx-ray diffractionB——
4WJNCrystal structure of SUMO1 in complex with phosphorylated PMLx-ray diffractionA——
4WJNCrystal structure of SUMO1 in complex with phosphorylated pmlx-ray diffractionA——
4WJOCrystal Structure of SUMO1 in complex with PMLx-ray diffractionA——
4WJOCrystal structure of SUMO1 in complex with pmlx-ray diffractionA——
4WJPCrystal Structure of SUMO1 in complex with phosphorylated Daxxx-ray diffractionA, C——
4WJPCrystal structure of SUMO1 in complex with phosphorylated daxxx-ray diffractionA, C——
4WJQCrystal Structure of SUMO1 in complex with Daxxx-ray diffractionA, C——
4WJQCrystal structure of SUMO1 in complex with daxxx-ray diffractionA, C——
5AEKCrystal structure of the human SENP2 C548S in complex with the human SUMO1 K48M F66Wx-ray diffractionB, D, F, H, J, L, N, P, R, T, V, X——
5AEKCrystal structure of the human SENP2 C548S in complex with the human SUMO1 K48M F66Wx-ray diffractionB, D, F, H, J, L, N, P, R, T, V, X——
5B7ASolution structure of LYS37 acetylated human SUMO1solution nmrA——
5B7ASolution structure of LYS37 acetylated human SUMO1solution nmrA——
5ELJIsoform-specific inhibition of SUMO-dependent protein-protein interactionsx-ray diffractionB——
5ELJIsoform-specific inhibition of sumo-dependent protein-protein interactionsx-ray diffractionB——

44 records more on the page itself.

Ligands

  • ZN · Zinc ion · in 6 records
  • VAY · {(1R,2R,3S,4R)-4-[(5-{4-[(1S)-1-(6-bromopyridin-2-yl)-1-hydroxyethyl]thiophene-2-carbonyl}pyrimidin-4-yl) amino]-2,3-dihydroxycyclopentyl}methyl sulfamate · in 2 records
  • VB7 · {(1R,2S,4R)-4-[(5-{4-[(1R)-3,4-dihydro-1H-2-benzopyran-1-yl]thiophene-2-carbonyl}pyrimidin-4-yl)amino]-2-hydroxycyclopentyl}methyl sulfamate · in 2 records
  • VBA · [(1R,2R,3S,4R)-4-{[5-(1-benzyl-1H-pyrazole-3-carbonyl) pyrimidin-4-yl]amino}-2,3-dihydroxycyclopentyl]methyl sulfamate · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.